{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:29:55Z","timestamp":1789115395469,"version":"build-2803163510"},"reference-count":182,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Macau University of Science and Technology Faculty Research Grants","award":["FRG-22-089-FMD"],"award-info":[{"award-number":["FRG-22-089-FMD"]}]},{"name":"Macau University of Science and Technology Faculty Research Grants","award":["FRG-22-088-FMD"],"award-info":[{"award-number":["FRG-22-088-FMD"]}]},{"name":"Macau University of Science and Technology Faculty Research Grants","award":["0097\/2022\/A2"],"award-info":[{"award-number":["0097\/2022\/A2"]}]},{"name":"Macau University of Science and Technology Faculty Research Grants","award":["0086\/2022\/A"],"award-info":[{"award-number":["0086\/2022\/A"]}]},{"name":"Macau Science and Technology Development Fund","award":["FRG-22-089-FMD"],"award-info":[{"award-number":["FRG-22-089-FMD"]}]},{"name":"Macau Science and Technology Development Fund","award":["FRG-22-088-FMD"],"award-info":[{"award-number":["FRG-22-088-FMD"]}]},{"name":"Macau Science and Technology Development Fund","award":["0097\/2022\/A2"],"award-info":[{"award-number":["0097\/2022\/A2"]}]},{"name":"Macau Science and Technology Development Fund","award":["0086\/2022\/A"],"award-info":[{"award-number":["0086\/2022\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The aim of this review is to explore the potential of new regenerative medicine approaches in the treatment of cholestatic liver fibrosis. Cholestatic liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and biliary atresia (BA), due to the accumulation of bile, often progress to liver fibrosis, cirrhosis, and liver failure. When the disease becomes severe enough to require liver transplantation. Deeply understanding the disease\u2019s progression and fibrosis formation is crucial for better diagnosis and treatment. Current liver fibrosis treatments mainly target the root causes and no direct treatment method in fibrosis itself. Recent advances in regenerative medicine offer a potential approach that may help find the ways to target fibrosis directly, offering hope for improved outcomes. We also summarize, analyze, and discuss the current state and benefits of regenerative medicine therapies such as mesenchymal stem cell (MSC) therapy, induced pluripotent stem cells (iPSCs), and organoid technology, which may help the treatment of cholestatic liver diseases. Focusing on the latest research may reveal new targets and enhance therapeutic efficacy, potentially leading to more effective management and even curative strategies for cholestatic liver diseases.<\/jats:p>","DOI":"10.3390\/cells13231997","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T09:18:32Z","timestamp":1733217512000},"page":"1997","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based Therapies"],"prefix":"10.3390","volume":"13","author":[{"given":"Wei-Lu","family":"Wang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9693-2234","authenticated-orcid":false,"given":"Haoran","family":"Lian","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqin","family":"Ye","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6231-3035","authenticated-orcid":false,"given":"Paul Kwong Hang","family":"Tam","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"},{"name":"Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"},{"name":"Precision Regenerative Medicine Research Centre, Medical Sciences Division, Macau University of Science and Technology, Macao SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"},{"name":"Faculty of Medicine, Macau University of Science and Technology, Macao SAR, China"},{"name":"Precision Regenerative Medicine Research Centre, Medical Sciences Division, Macau University of Science and Technology, Macao SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e22731","DOI":"10.1096\/fj.202201453R","article-title":"Liver-specific deletion of microRNA-34a alleviates ductular reaction and liver fibrosis during experimental cholestasis","volume":"37","author":"Wan","year":"2023","journal-title":"FASEB J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2328521","DOI":"10.1080\/07853890.2024.2328521","article-title":"Global burden of liver cirrhosis 1990-2019 and 20 years forecast: Results from the global burden of disease study 2019","volume":"56","author":"Wang","year":"2024","journal-title":"Ann. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The Cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"01","DOI":"10.35946\/arcr.v40.2.01","article-title":"Gender Differences in the Epidemiology of Alcohol Use and Related Harms in the United States","volume":"40","author":"White","year":"2020","journal-title":"Alcohol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-022-00681-5","article-title":"Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota","volume":"20","author":"Lindell","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.32074\/1591-951X-245","article-title":"Autoimmune biliary diseases: Primary biliary cholangitis and primary sclerosing cholangitis","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Patel, A.M., Liu, Y.S., Davies, S.P., Brown, R.M., Kelly, D.A., Scheel-Toellner, D., Reynolds, G.M., and Stamataki, Z. (2021). The Role of B Cells in Adult and Paediatric Liver Injury. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.729143"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lleo, A., Jepsen, P., Morenghi, E., Carbone, M., Moroni, L., Battezzati, P.M., Podda, M., Mackay, I.R., Gershwin, M.E., and Invernizzi, P. (2016). Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis. Sci. Rep., 6.","DOI":"10.1038\/srep25906"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOT.0000000000000392","article-title":"Liver transplantation around the world","volume":"22","author":"Trotter","year":"2017","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijsu.2020.05.024","article-title":"Expanding the donor pool for liver transplantation with marginal donors","volume":"82S","author":"Goldaracena","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Olgasi, C., Cucci, A., and Follenzi, A. (2020). iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176215"},{"key":"ref_17","unstructured":"Almajid, A.N., and Sugumar, K. (2024). Physiology, Bile. StatPearls, Treasure Island (FL) Ineligible Companies. Disclosure: Kavin Sugumar declares no relevant financial relationships with ineligible companies."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bph.12426","article-title":"GPBA: A GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation","volume":"171","author":"Lieu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Durnik, R., Sindlerova, L., Babica, P., and Jurcek, O. (2022). Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery. Molecules, 27.","DOI":"10.3390\/molecules27092961"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.10.3.409","article-title":"FXR: A target for cholestatic syndromes?","volume":"10","author":"Cai","year":"2006","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cai, X., Tacke, F., Guillot, A., and Liu, H. (2023). Cholangiokines: Undervalued modulators in the hepatic microenvironment. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1192840"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00018-024-05126-1","article-title":"Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication","volume":"81","author":"Liu","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell death and cell death responses in liver disease: Mechanisms and clinical relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00281-021-00869-6","article-title":"Role of bile acids in inflammatory liver diseases","volume":"43","author":"Evangelakos","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e25634","DOI":"10.1016\/j.heliyon.2024.e25634","article-title":"Reasons why women are more likely to develop primary biliary cholangitis","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: Epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin. Liver Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1053\/j.gastro.2021.02.061","article-title":"X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis","volume":"160","author":"Asselta","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.29783","article-title":"Primary biliary cholangitis, DNA, and beyond: The Relative contribution of genes","volume":"68","author":"Gulamhusein","year":"2018","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yasunami, M., Nakamura, H., Tokunaga, K., Kawashima, M., Nishida, N., Hitomi, Y., and Nakamura, M. (2017). Principal contribution of HLA-DQ alleles, DQB1*06:04 and DQB1*03:01, to disease resistance against primary biliary cholangitis in a Japanese population. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-11148-6"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhepr.2019.05.006","article-title":"Promoter hypermethylation of the AE2\/SLC4A2 gene in PBC","volume":"1","author":"Arenas","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.3390\/ijms16036432","article-title":"Primary biliary cirrhosis is a generalized autoimmune epithelitis","volume":"16","author":"Gao","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: Pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2009.00784.x","article-title":"Mechanisms of costimulation","volume":"229","author":"Sharpe","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1074\/jbc.M508342200","article-title":"Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity","volume":"281","author":"Patel","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2004.10.007","article-title":"Impaired clearance of dying cells in systemic lupus erythematosus","volume":"4","author":"Gaipl","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jmi.12019","article-title":"Embryo zebrafish segmentation using an improved hybrid method","volume":"250","author":"Wu","year":"2013","journal-title":"J. Microsc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2020.0028","article-title":"Current understanding of primary biliary cholangitis","volume":"27","author":"Tanaka","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2017.09.022","article-title":"Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis","volume":"1864","author":"Chang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1073\/pnas.1322778111","article-title":"Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate","volume":"111","author":"Kleinboelting","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/CS20181123","article-title":"Immunological abnormalities in patients with primary biliary cholangitis","volume":"133","author":"Ma","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12016-021-08904-y","article-title":"Antimitochondrial Antibodies: From Bench to Bedside","volume":"63","author":"Colapietro","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gou, H., Liu, S., Liu, L., Luo, M., Qin, S., He, K., and Yang, X. (2022). Obeticholic acid and 5beta-cholanic acid 3 exhibit anti-tumor effects on liver cancer through CXCL16\/CXCR6 pathway. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1095915"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e2003721","DOI":"10.1002\/advs.202003721","article-title":"Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells","volume":"8","author":"Wu","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Chai, J., Feng, X., Zhang, L., Chen, S., Cheng, Y., He, X., Yang, Y., He, Y., Wang, H., and Wang, R. (2015). Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120055"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e0056","DOI":"10.1097\/HC9.0000000000000056","article-title":"Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis","volume":"7","author":"Ghosh","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., and Marra, F. (2021). Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells, 10.","DOI":"10.3390\/cells10102759"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI93562","article-title":"The balancing act of the liver: Tissue regeneration versus fibrosis","volume":"128","author":"Huch","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of organ fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.32140","article-title":"Ductular reaction promotes intrahepatic angiogenesis through Slit2-Roundabout 1 signaling","volume":"75","author":"Coll","year":"2022","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis\u2014Their role in signaling and organ function","volume":"121","author":"Karsdal","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_61","first-page":"2381","article-title":"Cilostazol protects rats against alcohol-induced hepatic fibrosis via suppression of TGF-beta1\/CTGF activation and the cAMP\/Epac1 pathway","volume":"17","author":"Han","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"C698","DOI":"10.1152\/ajpcell.00486.2023","article-title":"Unraveling the complexities of fibrosis and ductular reaction in liver disease: Pathogenesis, mechanisms, and therapeutic insights","volume":"326","author":"Marakovits","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ajpath.2015.06.004","article-title":"Hepatic Progenitor Cells in Action: Liver Regeneration or Fibrosis?","volume":"185","author":"Kaur","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.gastro.2013.11.034","article-title":"Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion","volume":"146","author":"Williams","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.30150","article-title":"Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances","volume":"69","author":"Sato","year":"2019","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.32117","article-title":"Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases","volume":"75","author":"Lindor","year":"2022","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-023-01979-1","article-title":"New Therapies on the Horizon for Primary Biliary Cholangitis","volume":"84","author":"Tanaka","year":"2024","journal-title":"Drugs"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jhep.2021.01.013","article-title":"A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA","volume":"74","author":"Schattenberg","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MOG.0000000000000708","article-title":"Primary biliary cholangitis: Treatment","volume":"37","author":"Cazzagon","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Floreani, A., Gabbia, D., and De Martin, S. (2022). Obeticholic Acid for Primary Biliary Cholangitis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102464"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival","volume":"156","author":"Hansen","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15007","article-title":"Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis","volume":"41","author":"Mehta","year":"2021","journal-title":"Liver Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"103264","DOI":"10.1016\/j.jaut.2024.103264","article-title":"Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval","volume":"147","author":"Xu","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.cgh.2023.04.004","article-title":"Recent Advances in the Management of Primary Sclerosing Cholangitis","volume":"21","author":"Assis","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/JIR.S165330","article-title":"Role of biologics and biosimilars in inflammatory bowel disease: Current trends and future perspectives","volume":"11","author":"Rawla","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis\u2014A comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: A comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J. Autoimmun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3748\/wjg.v28.i21.2291","article-title":"Serological biomarkers for management of primary sclerosing cholangitis","volume":"28","author":"Tornai","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Jiang, B., Yuan, G., Wu, J., Wu, Q., Li, L., and Jiang, P. (2022). Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway. Biochim. Biophys. Acta Mol. Basis Dis., 1868.","DOI":"10.1016\/j.bbadis.2021.166320"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e162270","DOI":"10.1172\/jci.insight.162270","article-title":"CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis","volume":"8","author":"Greenman","year":"2023","journal-title":"JCI Insight"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/HEP.0000000000000317","article-title":"P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases","volume":"78","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HEP.0000000000000557","article-title":"Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis","volume":"79","author":"Heyerick","year":"2024","journal-title":"Hepatology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41586-024-07372-6","article-title":"Periportal macrophages protect against commensal-driven liver inflammation","volume":"629","author":"Miyamoto","year":"2024","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhepr.2019.10.003","article-title":"Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis","volume":"1","author":"Chen","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ortiz-Perez, A., Donnelly, B., Temple, H., Tiao, G., Bansal, R., and Mohanty, S.K. (2020). Innate Immunity and Pathogenesis of Biliary Atresia. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00329"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Li, X., Liu, R., Wang, Y., Zhu, W., Zhao, D., Wang, X., Yang, H., Gurley, E.C., Chen, W., and Hylemon, P.B. (2020). Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions. Cells, 9.","DOI":"10.3390\/cells9010190"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/105221620X15889714507961","article-title":"Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2(\/) Mouse Model of Primary Sclerosing Cholangitis","volume":"20","author":"Kyritsi","year":"2020","journal-title":"Gene Expr."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1096\/fj.201700097R","article-title":"Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation","volume":"31","author":"Wu","year":"2017","journal-title":"FASEB J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep4.1909","article-title":"FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2(-\/-) Mouse Model of Primary Sclerosing Cholangitis","volume":"6","author":"Zhou","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.dld.2021.04.028","article-title":"Treatment of primary sclerosing cholangitis","volume":"53","author":"Floreani","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","article-title":"Pathogenesis of biliary atresia: Defining biology to understand clinical phenotypes","volume":"12","author":"Asai","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jhep.2020.06.012","article-title":"Beta-amyloid deposition around hepatic bile ducts is a novel pathobiological and diagnostic feature of biliary atresia","volume":"73","author":"Babu","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.cell.2020.10.048","article-title":"Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.gene.2018.07.071","article-title":"Association of IL18 genetic polymorphisms with increased risk of Biliary atresia susceptibility in Southern Chinese children","volume":"677","author":"Liang","year":"2018","journal-title":"Gene"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2020.05.080","article-title":"Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia","volume":"159","author":"Zhao","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Davenport, M., Muntean, A., and Hadzic, N. (2021). Biliary Atresia: Clinical Phenotypes and Aetiological Heterogeneity. J. Clin. Med., 10.","DOI":"10.3390\/jcm10235675"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jhep.2013.05.010","article-title":"Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia","volume":"59","author":"Tucker","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1042\/CS20201366","article-title":"Down-regulation of STAT3 enhanced chemokine expression and neutrophil recruitment in biliary atresia","volume":"135","author":"Fu","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2022.06.015","article-title":"CD177(+) cells produce neutrophil extracellular traps that promote biliary atresia","volume":"77","author":"Zhang","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-013013","article-title":"Development of the Intrahepatic and Extrahepatic Biliary Tract: A Framework for Understanding Congenital Diseases","volume":"15","author":"Lemaigre","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/hepr.13060","article-title":"Intrahepatic bile duct primary cilia in biliary atresia","volume":"48","author":"Frassetto","year":"2018","journal-title":"Hepatol. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.devcel.2020.07.009","article-title":"Intestinal Regeneration: Regulation by the Microenvironment","volume":"54","author":"Hageman","year":"2020","journal-title":"Dev. Cell"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Lendahl, U., Lui, V.C.H., Chung, P.H.Y., and Tam, P.K.H. (2021). Biliary Atresia\u2014Emerging diagnostic and therapy opportunities. EBioMedicine, 74.","DOI":"10.1016\/j.ebiom.2021.103689"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41419-023-05615-4","article-title":"Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA\/S1PR2\/ZBP1\/p-MLKL axis","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hbpd.2020.12.007","article-title":"SOX9 in biliary atresia: New insight for fibrosis progression","volume":"20","author":"Saber","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.15252\/emmm.201707860","article-title":"SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis","volume":"9","author":"Athwal","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.dld.2016.05.001","article-title":"Histamine is correlated with liver fibrosis in biliary atresia","volume":"48","author":"Zhou","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1080\/21655979.2022.2041321","article-title":"Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia","volume":"13","author":"Ye","year":"2022","journal-title":"Bioengineered"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Ye, Y., Li, Z., Feng, Q., Chen, Z., Wu, Z., Wang, J., Ye, X., Zhang, D., Liu, L., and Gao, W. (2017). Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180896"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/jpet.121.001020","article-title":"Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-beta\/Smad Signaling in an Animal Model of Biliary Atresia","volume":"381","author":"Qiu","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cellsig.2014.01.003","article-title":"Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K\/Akt signaling","volume":"26","author":"Xiao","year":"2014","journal-title":"Cell Signal"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1293\/tox.2021-0018","article-title":"LPS-TLR4\/MD-2-TNF-alpha signaling mediates alcohol-induced liver fibrosis in rats","volume":"35","author":"Mou","year":"2022","journal-title":"J. Toxicol. Pathol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Min, J., Ningappa, M., So, J., Shin, D., Sindhi, R., and Subramaniam, S. (2020). Systems Analysis of Biliary Atresia Through Integration of High-Throughput Biological Data. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00966"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-024-00533-x","article-title":"Biliary atresia","volume":"10","author":"Tam","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/tp-23-504","article-title":"Effect of Kasai procedure on liver transplantation in children with biliary atresia: A systematic review and updated meta-analysis","volume":"13","author":"Liu","year":"2024","journal-title":"Transl. Pediatr."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2020.09.007","article-title":"Expanded circulating peripheral helper T cells in primary biliary cholangitis: Tph cells in PBC","volume":"131","author":"Yong","year":"2021","journal-title":"Mol. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: A review of literature","volume":"56","author":"Matinato","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","article-title":"New Treatment Paradigms in Primary Biliary Cholangitis","volume":"21","author":"Levy","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bbadis.2017.07.026","article-title":"Pathogenesis of biliary fibrosis","volume":"1864","author":"Pinzani","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Yang, Y., Zhao, R.C., and Zhang, F. (2022). Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: Advances, challenges, and perspectives. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.933565"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13287-018-0979-x","article-title":"Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9","volume":"9","author":"Fan","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2040622321993442","DOI":"10.1177\/2040622321993442","article-title":"Mesenchymal stem cell-based treatment in autoimmune liver diseases: Underlying roles, advantages and challenges","volume":"12","author":"He","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","article-title":"Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages","volume":"13","author":"Tian","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Angioni, R., Cali, B., Vigneswara, V., Crescenzi, M., Merino, A., Sanchez-Rodriguez, R., Liboni, C., Hoogduijn, M.J., Newsome, P.N., and Muraca, M. (2020). Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228874"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","article-title":"Mesenchymal stem cell therapy in decompensated liver cirrhosis: A long-term follow-up analysis of the randomized controlled clinical trial","volume":"15","author":"Shi","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","article-title":"Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease","volume":"159","author":"Ramli","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13619-022-00148-1","article-title":"Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids","volume":"12","author":"Wu","year":"2023","journal-title":"Cell Regen."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1038\/s41467-021-26410-9","article-title":"A human multi-lineage hepatic organoid model for liver fibrosis","volume":"12","author":"Guan","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12015-021-10262-3","article-title":"Review of the Current Trends in Clinical Trials Involving Induced Pluripotent Stem Cells","volume":"18","author":"Kim","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00204-019-02437-2","article-title":"Mechanisms and in vitro models of drug-induced cholestasis","volume":"93","author":"Gijbels","year":"2019","journal-title":"Arch. Toxicol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.7150\/ijbs.90441","article-title":"Hepatobiliary organoids differentiated from hiPSCs relieve cholestasis-induced liver fibrosis in nonhuman primates","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.jhepr.2022.100446","article-title":"Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Nghiem-Rao, T.H., Pfeifer, C., Asuncion, M., Nord, J., Schill, D., Pulakanti, K., Patel, S.B., Cirillo, L.A., and Rao, S. (2021). Human induced pluripotent stem cell derived hepatocytes provide insights on parenteral nutrition associated cholestasis in the immature liver. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-90510-1"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","article-title":"Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications","volume":"16","author":"Liu","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e2007949","DOI":"10.1002\/adma.202007949","article-title":"Bioengineering Approaches for the Advanced Organoid Research","volume":"33","author":"Yi","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-0716-1382-5_23","article-title":"Mouse Models of Liver Fibrosis","volume":"2299","author":"Ravichandra","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Yuan, J., Li, X., and Yu, S. (2022). Cancer organoid co-culture model system: Novel approach to guide precision medicine. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1061388"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.3389\/ti.2024.12708","article-title":"Cholangiocyte Organoids in Liver Transplantation; a Comprehensive Review","volume":"37","author":"Rejas","year":"2024","journal-title":"Transpl. Int."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10456-022-09842-9","article-title":"In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed","volume":"25","author":"Bonanini","year":"2022","journal-title":"Angiogenesis"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"AlShmmari, S.K., Fardous, R.S., Shinwari, Z., Cialla-May, D., Popp, J., Ramadan, Q., and Zourob, M. (2024). Hepatic spheroid-on-a-chip: Fabrication and characterization of a spheroid-based in vitro model of the human liver for drug screening applications. Biomicrofluidics, 18.","DOI":"10.1063\/5.0210955"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13287-023-03476-4","article-title":"Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases","volume":"14","author":"Yu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41591-020-1050-x","article-title":"Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: A phase I, multicenter, open-label, dose-escalation study","volume":"26","author":"Bloor","year":"2020","journal-title":"Nat. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","article-title":"A Brief Overview of Global Trends in MSC-Based Cell Therapy","volume":"18","author":"Jovic","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13287-022-02751-0","article-title":"Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: A systematic review","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.06.033","article-title":"Prolonged engraftment of transplanted hepatocytes in the liver by transient pro-survival factor supplementation using ex vivo mRNA transfection","volume":"285","author":"Matsui","year":"2018","journal-title":"J. Control Release"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41417-020-0179-6","article-title":"Genetically engineered mesenchymal stem cells: Targeted delivery of immunomodulatory agents for tumor eradication","volume":"27","author":"Mosallaei","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"eaax5516","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Silver, S.E., Barrs, R.W., and Mei, Y. (2021). Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.707890"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Xu, Y., Zhou, X., Wang, X., Jin, Y., Zhou, L., and Ye, J. (2024). Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis. Biomed. Pharmacother., 176.","DOI":"10.1016\/j.biopha.2024.116848"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3324\/haematol.2021.279561","article-title":"Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma","volume":"107","author":"Bouard","year":"2022","journal-title":"Haematologica"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41419-022-05450-z","article-title":"Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling","volume":"13","author":"Tian","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13287-020-02092-w","article-title":"Precision regenerative medicine","volume":"12","author":"Lightner","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Degrassi, I., Leonardi, I., Di Profio, E., Montanari, C., Zuccotti, G., and Verduci, E. (2023). Fat-Soluble Vitamins Deficiency in Pediatric Cholestasis: A Scoping Review. Nutrients, 15.","DOI":"10.3390\/nu15112491"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: Metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Wang, X., Wei, Y., Yang, Y., Yang, Y., Li, H., Li, Y., Zhang, F., and Wang, L. (2023). Animal models of primary biliary cholangitis: Status and challenges. Cell Biosci., 13.","DOI":"10.1186\/s13578-023-01170-9"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gutjnl-2021-326500","article-title":"Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC","volume":"72","author":"Awoniyi","year":"2023","journal-title":"Gut"},{"key":"ref_170","first-page":"e65044","article-title":"A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia","volume":"192","author":"Wang","year":"2023","journal-title":"J. Vis. Exp."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/joim.13767","article-title":"Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases","volume":"295","author":"Li","year":"2024","journal-title":"J. Intern. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2021.06.036","article-title":"24-Norursodeoxycholic acid reshapes immunometabolism in CD8(+) T cells and alleviates hepatic inflammation","volume":"75","author":"Zhu","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jhep.2022.10.007","article-title":"Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases(dagger)","volume":"78","author":"Nevens","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.32107","article-title":"Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia","volume":"75","author":"Amarachintha","year":"2022","journal-title":"Hepatology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.4360","article-title":"Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids","volume":"23","author":"Sampaziotis","year":"2017","journal-title":"Nat. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/HEP.0000000000000026","article-title":"TWEAK\/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia","volume":"77","author":"Short","year":"2023","journal-title":"Hepatology"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Meng, L., Liu, J., Wang, J., Du, M., Zhang, S., Huang, Y., Shen, Z., Dong, R., Chen, G., and Zheng, S. (2021). Characteristics of the Gut Microbiome and IL-13\/TGF-beta1 Mediated Fibrosis in Post-Kasai Cholangitis of Biliary Atresia. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.751204"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s13287-021-02616-y","article-title":"Activation of the EGFR-PI3K-CaM pathway by PRL-1-overexpressing placenta-derived mesenchymal stem cells ameliorates liver cirrhosis via ER stress-dependent calcium","volume":"12","author":"Kim","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aaz6964","article-title":"Cholangiocyte organoids can repair bile ducts after transplantation in the human liver","volume":"371","author":"Sampaziotis","year":"2021","journal-title":"Science"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Liu, Y., Peng, L., Li, L., Huang, C., Shi, K., Meng, X., Wang, P., Wu, M., Li, L., and Cao, H. (2021). 3D-bioprinted BMSC-laden biomimetic multiphasic scaffolds for efficient repair of osteochondral defects in an osteoarthritic rat model. Biomaterials, 279.","DOI":"10.1016\/j.biomaterials.2021.121216"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJMp2118019","article-title":"Progress toward Pig-to-Human Xenotransplantation","volume":"386","author":"Pierson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/d41586-022-01861-2","article-title":"Clinical trials for pig-to-human organ transplants inch closer","volume":"607","author":"Kozlov","year":"2022","journal-title":"Nature"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/23\/1997\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:45:59Z","timestamp":1760114759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/23\/1997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":182,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cells13231997"],"URL":"https:\/\/doi.org\/10.3390\/cells13231997","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}